קונבריזה
Valsts: Izraēla
Valoda: ivrits
Klimata pārmaiņas: Ministry of Health
Daži šī produkta dokumenti pašlaik nav pieejami. Varat nosūtīt pieprasījumu mūsu klientu apkalpošanas dienestam, un mēs jums paziņosim, tiklīdz mēs tos varēsim iegūt.
Nosūtīt pieprasījumu.
Nosūtīt pieprasījumu.
Aktīvā sastāvdaļa:
BAZEDOXIFENE AS ACETATE 20 MG
Pieejams no:
NEOPHARM LTD
ATĶ kods:
G03XC02
Zāļu forma:
COATED TABLETS
Ievadīšanas:
PER OS
Ražojis:
PFIZER IRELAND PHARMACEUTICALS
Ārstniecības grupa:
BAZEDOXIFENE
Ārstēšanas norādes:
CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit
Autorizācija datums:
2013-04-01
